Form 4: Hims & Hers COO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi sold 97,289 shares of Class A Common Stock for $24.69 per share pursuant to a pre-arranged trading plan.

Summary

• Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc. (HIMS), reported a sale of company stock.
• On March 17, 2026, Chi disposed of 97,289 shares of Class A Common Stock.
• The shares were sold at a price of $24.69 per share.
• Following this transaction, Michael Chi beneficially owns 407,282 shares of Class A Common Stock.
• The sale was executed under a Rule 10b5-1 trading plan, which was adopted on March 4, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale, it was conducted under a pre-arranged 10b5-1 trading plan, which mitigates the immediate negative signal often associated with insider selling.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when pre-planned under a 10b5-1 plan, are routinely monitored by investors for insights into management's perspective on future stock performance, though a single planned sale is less indicative than a series of unplanned sales.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a slight negative signal, though the 10b5-1 plan context reduces its severity.

Key Dates

Recommendation

The sale by Chief Operating Officer Michael Chi was executed under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not a reaction to immediate company news. While insider selling can sometimes be a bearish signal, a single planned transaction of this size does not fundamentally alter the investment thesis for Hims & Hers Health, Inc. A 'hold' recommendation is appropriate as investors should continue to monitor broader company performance and market trends rather than reacting solely to this planned insider sale.

Keywords

Hims & Hers Health, HIMS, Michael Chi, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Chief Operating Officer, Healthcare Technology